Skip to main content

Paul Grimsrud

Assistant Professor in Medicine
Medicine, Endocrinology, Metabolism, and Nutrition
104775, Durham, NC 27701
300 N Duke Street, 48-208K, Durham, NC 27701

Overview


Paul Grimsrud is an Assistant professor of Medicine—in the Division of Endocrinology, Metabolism, and Nutrition—and Proteomics Section Leader at the Duke Molecular Physiology Institute. He completed a PhD in Biochemistry at the University of Minnesota-Twin Cities and a postdoctoral fellowship at the University of Wisconsin-Madison. His research combines mass spectrometry-based proteomics with complementary biochemical approaches to characterize the regulation of metabolism and signaling by protein post-translational modifications (PTMs). He is particularly interested in mechanisms that link altered mitochondrial function to metabolic diseases, such as heart failure, type 2 diabetes, and cancer. He works with colleagues to apply quantitative PTM measurements to relevant model systems, leverage bioinformatics tools to develop testable hypotheses from large-scale data, and characterize mechanisms of PTM-mediated metabolic control.

Current Appointments & Affiliations


Assistant Professor in Medicine · 2021 - Present Medicine, Endocrinology, Metabolism, and Nutrition, Medicine
Member of Duke Molecular Physiology Institute · 2020 - Present Duke Molecular Physiology Institute, Institutes and Centers

In the News


Published June 27, 2022
Muoio and Paul Grimsrud Receive Multi-PI NIH Grant
Published September 3, 2021
Paul Grimsrud Receives 2021 NCDRC Pilot Grant

View All News

Recent Publications


Cysteine S-acetylation is a widespread post-translational modification on metabolic proteins

Journal Article Npj Metabolic Health and Disease · December 1, 2025 Protein acetylation is a fundamental regulatory mechanism occurring primarily on lysine amino acids. Here we report systematic in vivo characterization of cysteine S-acetylation as a widespread post-translational modification in mammalian tissues. By devel ... Full text Cite

Pathway coessentiality mapping reveals complex II is required for de novo purine biosynthesis in acute myeloid leukaemia.

Journal Article Nat Metab · December 2025 Understanding how cellular pathways interact is crucial for treating complex diseases like cancer. Individual gene-gene interaction studies have provided valuable insights, but may miss pathways working together. Here we develop a multi-gene approach to pa ... Full text Link to item Cite

Region-Specific Quantification of 2-Hydroxyglutarate Enantiomers in Murine Brain during Mitochondrial Complex I Deficiency.

Journal Article ACS Chem Neurosci · November 5, 2025 The Ndufs4-/- mouse is a model of mitochondrial Complex I deficiency that contributes to altered production of the tricarboxylic acid cycle metabolites. We hypothesized that l-2-hydroxyglutarate (l-2-HG) levels would be elevated in the pathologically affec ... Full text Link to item Cite
View All Publications

Recent Grants


Mechanisms of lipid-induced bioenergetic stress in muscle

ResearchCo Investigator · Awarded by National Institute of Diabetes and Digestive and Kidney Diseases · 2010 - 2028

Stalling cancer at the ribosome

ResearchCollaborator · Awarded by V Foundation for Cancer Research · 2025 - 2028

Novel roles of PDK4 in regulating mitochondrial protein phosphorylation, carbon flux and metabolic resilience

ResearchCo-Principal Investigator · Awarded by National Institute of Diabetes and Digestive and Kidney Diseases · 2022 - 2027

View All Grants

Education, Training & Certifications


University of Minnesota, Twin Cities · 2008 Ph.D.